PCI Biotech interim Q3 2022 report
23 nov. 2022 01h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 23 November 2022 – PCI Biotech (OSE: PCIB), today announces its interim Q3 2022 results. Please find enclosed the report and presentation. Highlights Corporate*Efforts to finance a Ph...
PCI Biotech: Invitation to Q3 2022 results presentation
17 nov. 2022 11h42 HE
|
PCI Biotech Holding ASA
Oslo, Norway, 17 November 2022 - PCI Biotech (OSE: PCIB) invites to an online presentation of the company's Q3 2022 interim report on Wednesday 23 November 2022, 08:30am – 09:30am CET (local time). ...
Correction: PCI Biotech: Mandatory notification regarding trade of shares
08 sept. 2022 05h58 HE
|
PCI Biotech Holding ASA
Borkenholm AS has on 8 September 2022 purchased 4,000 shares in PCI Biotech Holding ASA ("PCI Biotech") at an average price of NOK 1.948 per share. Borkenholm AS is a related party to board member...
PCI Biotech: Mandatory notification regarding trade of shares
08 sept. 2022 05h03 HE
|
PCI Biotech Holding ASA
Borkenholm AS has on 8 September 2022 purchased 4,000 shares in PCI Biotech Holding ASA ("PCI Biotech") at an average price of NOK 1.948 per share. Borkenholm AS is a related party to board member...
PCI Biotech interim first-half year 2022 results
31 août 2022 01h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 31 August 2022 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim first-half year 2022 results. Please find enclosed the report and...
PCI Biotech: Invitation to first-half year 2022 results presentation
26 août 2022 05h34 HE
|
PCI Biotech Holding ASA
Oslo, Norway, 26 August 2022 - PCI Biotech (OSE: PCIB) invites to an online presentation of the company's first-half year 2022 interim report on Wednesday 31 August 2022, 08:30am – 09:30am CEST...
PCI Biotech: Company update
18 août 2022 12h05 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 18 August 2022 – PCI Biotech (OSE: PCIB), a cancer-focused biopharma company developing innovative therapeutics that address significant unmet medical needs, today announced that the...
Minutes from Annual General Meeting 2022
25 mai 2022 05h47 HE
|
PCI Biotech Holding ASA
Oslo, 25 May 2022. The Annual General Meeting in PCI Biotech Holding ASA took place today, 25 May 2022. All proposals were resolved by the Annual General Meeting as presented in the notice convening...
Disclosure of voting rights for Chairman of the Board
24 mai 2022 04h44 HE
|
PCI Biotech Holding ASA
Oslo, 24 May 2022. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall...
PCI Biotech interim first quarter 2022 results
11 mai 2022 01h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 11 May 2022 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q1 2022 results. Please find enclosed the report and presentation. ...